Bain Capital: Atsena Therapeutics Inks $150M Series C Financing
DURHAM, NC, Atsena Therapeutics, a clinical-stage gene therapy company, announced the successful close of an oversubscribed $150 million Series C financing.
Read full article »
Bain Capital is a Massachusetts-based investment company that provides services such as venture capital, credit, and public equity for enterprises.
Read more